dc.contributor | IDIAP Jordi Gol |
dc.contributor.author | Lestón Vázquez, Marta |
dc.contributor.author | Gomez-Lumbreras, Ainhoa |
dc.contributor.author | Prat Vallverdú, Oriol |
dc.contributor.author | Vedia Urgell, Cristina |
dc.contributor.author | Giner-Soriano, Maria |
dc.contributor.author | Morros, Rosa |
dc.contributor.author | MARSAL MORA, JOSEP RAMON |
dc.contributor.author | Vilaplana-Carnerero, Carles |
dc.date.accessioned | 2023-08-24T07:57:15Z |
dc.date.available | 2023-08-24T07:57:15Z |
dc.date.issued | 2023-08-22 |
dc.identifier.citation | Lestón Vázquez M, Vilaplana-Carnerero C, Gomez-Lumbreras A, Prat-Vallverdu O, Ramon Marsal J, Vedia Urgell C, Soriano, et al. Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain. BMJ Open. 2023 Aug 22;13(8):e071335. |
dc.identifier.issn | 2044-6055 |
dc.identifier.uri | https://hdl.handle.net/11351/10143 |
dc.description | Clinical pharmacology; Primary care; Reproductive medicine |
dc.description.abstract | Objectives: To develop an algorithm to identify pregnancy episodes in women at childbearing age using SIDIAP (Information System for the Improvement of Research in Primary Care) data (Catalunya, Spain). To describe drugs dispensed during gestation.
Design: Construction of an algorithm to identify all pregnancy episodes occurred from January 2011 to June 2020 in women aged 12–50. The variables used to create the algorithm include first day of last menstrual period, reasons for pregnancy termination and diagnoses registered in the primary healthcare records. Population-based cohort study including the pregnancy episodes identified by the algorithm.
Setting: Catalonia, Spain.
Participants: All women aged 12–50 with at least one pregnancy episode occurred during January 2011–June 2020.
Interventions: No interventions performed.
Primary and secondary outcome measures: Identification of pregnancy episodes through an algorithm and description of drug exposure.
Results: We identified 327 865 pregnancy episodes in 250 910 people with a mean age of 31.3 years. During the study period, 83.4% of the episodes were exposed to at least one drug. The most frequent groups dispensed were iron preparations (48% of pregnancy episodes), iodine therapy (40.2%), analgesics and antipyretics (28%), penicillins (19.8%), vitamin B12 plus folic acid (19.7%) and non-steroidal anti-inflammatory drugs (NSAIDs, 15.1%). The supplements were more frequently dispensed at least twice, and the drugs for acute conditions were mainly dispensed only once during the pregnancy episode.
Conclusions: We developed an algorithm to automatically identify the pregnancy periods in SIDIAP. We described prescription drugs used during pregnancy. The most used ones were supplements, analgesics, NSAID or antibiotics. SIDIAP might be an efficient database to study drug safety during pregnancy and the consequences of drug use in the offspring. |
dc.language.iso | eng |
dc.publisher | BMJ |
dc.relation.ispartofseries | BMJ Open;13(8) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Farmacologia clínica |
dc.subject | Embaràs |
dc.subject | Salut reproductiva |
dc.subject | Medicaments - Administració |
dc.subject.mesh | Pharmacology, Clinical |
dc.subject.mesh | Pregnancy |
dc.subject.mesh | Reproductive Health |
dc.subject.mesh | Prescription Drugs |
dc.title | Drug exposure during pregnancy in primary care: an algorithm and observational study from SIDIAP database, Catalunya, Spain |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1136/ bmjopen-2022-071335 |
dc.subject.decs | farmacología clínica |
dc.subject.decs | embarazo |
dc.subject.decs | salud reproductiva |
dc.subject.decs | medicamentos por prescripción |
dc.relation.publishversion | https://doi.org/10.1136/bmjopen-2022-071335 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Lestón Vázquez M] Àrea del Medicament i Servei de Farmàcia, Gerència d'Atenció Primària Barcelona Ciutat, Institut Català de la Salut (ICS), Generalitat de Catalunya, Barcelona, Spain. Universitat Autònoma de Barcelona (UAB), Bellaterra (Cerdanyola del Vallès), Spain. [Vilaplana-Carnerero C, Giner-Soriano M, Morros R] Universitat Autònoma de Barcelona (UAB), Bellaterra (Cerdanyola del Vallès), Spain. Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. [Gomez-Lumbreras A] College of Pharmacy, Department of Pharmacotherapy, University of Utah, Salt Lake City, Utah, USA. [Prat-Vallverdu O] Marketing farmacéutico & Investigación clínica, Barcelona, Spain. Former employee at IDIAPJGol, Barcelona, Spain. [Ramon Marsal J] Former employee at IDIAPJGol, Barcelona, Spain. RTI Health Solutions Barcelona, Barcelona, Spain. [Vedia Urgell C] Universitat Autònoma de Barcelona (UAB), Bellaterra (Cerdanyola del Vallès), Spain. Unitat de farmàcia, Servei d’Atenció Primària Barcelonès Nord i Maresme, Institut Català de la Salut (ICS), Generalitat de Catalunya, Badalona, Spain |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |